Czechia· CZ-0238765

SPRAVATO

A esketamine product containing esketamine hydrochloride, registered in Czechia by Janssen-Cilag International N.V., Beerse. The same ATC class is registered in 11 of our 19 countries.

ATC N06AX27

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedSPRAVATOATCN06AX27REGISTER NO.CZ-0238765PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Esketamine is registered in 11 of 19 countries.

Countries holding a registration under ATC N06AX27 (esketamine), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Esketamine · ATC N06AX27

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of esketamine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Esketamine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$66.47
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
ESKETAMINE HYDROCHLORIDE
Manufacturer
Janssen-Cilag International N.V., Beerse
Country
Czechia (CZ)
ATC code
N06AX27
ATC class
Esketamine
Defined daily dose
8 mg, N
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0238765
    1
    CZK 5740.82

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

91 interactions on record for esketamine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Esketamine · interactions on record

91 records

  • 7 severe
  • 84 moderate

Most severe, free to view

  • PhentermineA08AA01severe
  • FenfluramineA08AA02severe
  • MazindolA08AA05severe
  • FenfluramineN03AX26severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Esketamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All esketamine products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Escetex, Eskelan
  • Belgium · Esketamine Kalceks, Vesierra
  • Germany · Esketamin, Esketamin Inresa
  • Denmark · Esketamine Orifarm, S-Ketamin Pfizer
  • Estonia · Esketex
  • Finland · Esketamine Kalceks, Esketamine Orifarm
  • France · Eskesia, Esketamine Renaudin
  • United Kingdom (Northern Ireland) · Esketamine Idd, Esketamine Kalceks
  • Croatia · Esgamda
  • Iceland · S-Ketamin Pfizer, Spravato
  • Liechtenstein · Spravato
  • Luxembourg · Vesierra
  • Latvia · Esketamine Kalceks
  • Netherlands · Esketamine Focus, Esketamine Idd
  • Norway · Ketanest, Sinmelan
  • Sweden · Esketamine Kalceks, Esketamine Orifarm
  • Slovenia · Esketamin Kalceks, Sinmelan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b41aaefe-1b28-40a7-a729-fc9b400cb2bc
GET /v1/drugs/b41aaefe-1b28-40a7-a729-fc9b400cb2bc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "NAS SPR SOL",
  "source": "sukl",
  "strength": "28MG",
  "pack_size": "1",
  "substance": "ESKETAMINE HYDROCHLORIDE",
  "cz_kod_sukl": "0238765",
  "product_type": "CH",
  "substance_codes": "17618",
  "registration_state": "R",
  "registration_number": "EU/1/19/1410/001"
}

See everything about esketamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.